Ultragenyx Analyst Day Presentation

Most productive rare disease company in the industry 4 products across 5 indications approved in 10 years ♥ Evkeeza CRYSVITA DOJOLVI burosumab Largest clinical pipeline in rare disease Mepsevii® 3 Confidential and Proprietary modes targeting 6 late-stage studies 4 cause of disease ultragenyx

View entire presentation